Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 24

Related Articles by Review for PubMed (Select 23216621)

1.

Endogenous protein C has a protective role during Gram-negative pneumosepsis (melioidosis).

Kager LM, Wiersinga WJ, Roelofs JJ, Meijers JC, Zeerleder SS, Esmon CT, van't Veer C, van der Poll T.

J Thromb Haemost. 2013 Feb;11(2):282-92. doi: 10.1111/jth.12094.

PMID:
23216621
2.

The coagulation system in melioidosis: from pathogenesis to new treatment strategies.

Kager LM, van der Poll T, Wiersinga WJ.

Expert Rev Anti Infect Ther. 2014 Aug;12(8):993-1002. doi: 10.1586/14787210.2014.928198. Epub 2014 Jun 25. Review.

PMID:
24962103
3.

Crosstalk between inflammation and coagulation: the lessons of sepsis.

van der Poll T, Levi M.

Curr Vasc Pharmacol. 2012 Sep;10(5):632-8. Review.

PMID:
22272914
4.

The cytoprotective protein C pathway.

Mosnier LO, Zlokovic BV, Griffin JH.

Blood. 2007 Apr 15;109(8):3161-72. Epub 2006 Nov 16. Review.

5.

The protein C pathway and sepsis.

Della Valle P, Pavani G, D'Angelo A.

Thromb Res. 2012 Mar;129(3):296-300. doi: 10.1016/j.thromres.2011.11.013. Epub 2011 Dec 7. Review.

PMID:
22154246
6.

Inflammation and coagulation. An overview.

Petäjä J.

Thromb Res. 2011 Jan;127 Suppl 2:S34-7. doi: 10.1016/S0049-3848(10)70153-5. Review.

PMID:
21193113
7.

Protective mechanisms of activated protein C in severe inflammatory disorders.

Neyrinck AP, Liu KD, Howard JP, Matthay MA.

Br J Pharmacol. 2009 Oct;158(4):1034-47. doi: 10.1111/j.1476-5381.2009.00251.x. Epub 2009 May 14. Review.

8.

Protein C anticoagulant pathway and its role in controlling microvascular thrombosis and inflammation.

Esmon CT.

Crit Care Med. 2001 Jul;29(7 Suppl):S48-51; discussion 51-2. Review.

PMID:
11445734
9.

Activated protein C action in inflammation.

Sarangi PP, Lee HW, Kim M.

Br J Haematol. 2010 Mar;148(6):817-33. doi: 10.1111/j.1365-2141.2009.08020.x. Epub 2009 Dec 8. Review.

10.
11.

Protein C in critical illness.

Mann HJ, Short MA, Schlichting DE.

Am J Health Syst Pharm. 2009 Jun 15;66(12):1089-96. doi: 10.2146/ajhp080276. Review.

PMID:
19498123
12.

Mechanisms of anticoagulant and cytoprotective actions of the protein C pathway.

Bouwens EA, Stavenuiter F, Mosnier LO.

J Thromb Haemost. 2013 Jun;11 Suppl 1:242-53. doi: 10.1111/jth.12247. Review.

13.

New therapeutic applications for the anticoagulant, activated protein C.

Jackson C, Whitmont K, Tritton S, March L, Sambrook P, Xue M.

Expert Opin Biol Ther. 2008 Aug;8(8):1109-22. doi: 10.1517/14712598.8.8.1109 . Review.

PMID:
18613763
14.

Activated protein C: a promising drug with multiple effects?

Loubele ST, Spronk HM, Ten Cate H.

Mini Rev Med Chem. 2009 May;9(5):620-6. Review.

PMID:
19456292
15.

Activated protein C--an anticoagulant that does more than stop clots.

Jackson CJ, Xue M.

Int J Biochem Cell Biol. 2008;40(12):2692-7. doi: 10.1016/j.biocel.2007.12.013. Epub 2008 Jan 3. Review.

PMID:
18249579
16.

Science review: role of coagulation protease cascades in sepsis.

Riewald M, Ruf W.

Crit Care. 2003 Apr;7(2):123-9. Epub 2002 Oct 1. Review.

17.

Cytoprotective-selective activated protein C therapy for ischaemic stroke.

Mosnier LO, Zlokovic BV, Griffin JH.

Thromb Haemost. 2014 Nov;112(5):883-92. doi: 10.1160/TH14-05-0448. Epub 2014 Sep 18. Review.

PMID:
25230930
18.

Activated protein C and sepsis.

O'Brien LA, Gupta A, Grinnell BW.

Front Biosci. 2006 Jan 1;11:676-98. Review.

PMID:
16146761
19.

Activated protein C.

Griffin JH, Fernández JA, Gale AJ, Mosnier LO.

J Thromb Haemost. 2007 Jul;5 Suppl 1:73-80. Review.

PMID:
17635713
20.

Activated protein C based therapeutic strategies in chronic diseases.

Bock F, Shahzad K, Vergnolle N, Isermann B.

Thromb Haemost. 2014 Apr 1;111(4):610-7. doi: 10.1160/TH13-11-0967. Epub 2014 Mar 20. Review.

PMID:
24652581
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk